{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T09:17:52Z","timestamp":1793783872108,"version":"4.6.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T00:00:00Z","timestamp":1528675200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013822","name":"Kurdistan university of medical sciences","doi-asserted-by":"crossref","award":["94\/67"],"award-info":[{"award-number":["94\/67"]}],"id":[{"id":"10.13039\/501100013822","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Equity Health"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12939-018-0787-z","type":"journal-article","created":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T13:17:27Z","timestamp":1528723047000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Perceived barriers to methadone maintenance treatment among Iranian opioid users"],"prefix":"10.1186","volume":"17","author":[{"given":"Maryam","family":"Khazaee-Pool","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Moeeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Ponnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arezoo","family":"Fallahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Jahangiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahereh","family":"Pashaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,11]]},"reference":[{"issue":"4","key":"787_CR1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.drugpo.2011.09.001","volume":"23","author":"M Malekinejad","year":"2012","unstructured":"Malekinejad M, Vazirian M. Transition to injection amongst opioid users in Iran: implications for harm reduction. International Journal of Drug Policy. 2012;23(4):333\u20137.","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"787_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12888-016-0973-8","volume":"16","author":"M Moeeni","year":"2016","unstructured":"Moeeni M, et al. Predictors of time to relapse in amphetamine-type substance users in the matrix treatment program in Iran: a cox proportional hazard model application. BMC psychiatry. 2016;16(1):1.","journal-title":"BMC psychiatry"},{"issue":"4","key":"787_CR3","first-page":"291","volume":"14","author":"T Pashaei","year":"2014","unstructured":"Pashaei T, et al. Predictors of treatment retention in a major methadone maintenance treatment program in Iran: a survival analysis. Journal of research in health sciences. 2014;14(4):291\u20135.","journal-title":"Journal of research in health sciences"},{"issue":"2","key":"787_CR4","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3390\/ijerph6020787","volume":"6","author":"ND Zaller","year":"2009","unstructured":"Zaller ND, et al. Attitudes toward methadone among out-of-treatment minority injection drug users: implications for health disparities. Int J Environ Res Public Health. 2009;6(2):787\u201397.","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"787_CR5","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.addbeh.2012.01.020","volume":"37","author":"H Xu","year":"2012","unstructured":"Xu H, et al. Misconceptions toward methadone maintenance treatment (MMT) and associated factors among new MMT users in Guangzhou, China. Addict Behav. 2012;37(5):657\u201362.","journal-title":"Addict Behav"},{"key":"787_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jsat.2015.01.014","volume":"54","author":"A Vijay","year":"2015","unstructured":"Vijay A, et al. Treatment readiness, attitudes toward, and experiences with methadone and buprenorphine maintenance therapy among people who inject drugs in Malaysia. J Subst Abus Treat. 2015;54:29\u201336.","journal-title":"J Subst Abus Treat"},{"issue":"Suppl 1","key":"787_CR7","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1097\/QAI.0b013e318209751e","volume":"56","author":"FL Altice","year":"2011","unstructured":"Altice FL, et al. HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine\/naloxone treatment within HIV clinical care settings: results from a multisite study. Journal of acquired immune deficiency syndromes (1999). 2011;56(Suppl 1):S22.","journal-title":"Journal of acquired immune deficiency syndromes (1999)"},{"issue":"2","key":"787_CR8","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jsat.2007.04.003","volume":"34","author":"WS Cartwright","year":"2008","unstructured":"Cartwright WS. Economic costs of drug abuse: financial, cost of illness, and services. J Subst Abus Treat. 2008;34(2):224\u201333.","journal-title":"J Subst Abus Treat"},{"issue":"9738","key":"787_CR9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0140-6736(10)60829-X","volume":"376","author":"FL Altice","year":"2010","unstructured":"Altice FL, et al. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet. 2010;376(9738):367\u201387.","journal-title":"Lancet"},{"issue":"9904","key":"787_CR10","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/S0140-6736(13)61530-5","volume":"382","author":"L Degenhardt","year":"2013","unstructured":"Degenhardt L, et al. Global burden of disease attributable to illicit drug use and dependence: findings from the global burden of disease study 2010. Lancet. 2013;382(9904):1564\u201374.","journal-title":"Lancet"},{"issue":"9719","key":"787_CR11","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/S0140-6736(10)60232-2","volume":"375","author":"BM Mathers","year":"2010","unstructured":"Mathers BM, et al. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010;375(9719):1014\u201328.","journal-title":"Lancet"},{"issue":"4","key":"787_CR12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jsat.2005.02.007","volume":"28","author":"L Amato","year":"2005","unstructured":"Amato L, et al. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. J Subst Abus Treat. 2005;28(4):321\u20139.","journal-title":"J Subst Abus Treat"},{"issue":"1","key":"787_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.drugpo.2008.07.004","volume":"21","author":"JA Peterson","year":"2010","unstructured":"Peterson JA, et al. Why don\u2019t out-of-treatment individuals enter methadone treatment programmes? International Journal of Drug Policy. 2010;21(1):36\u201342.","journal-title":"International Journal of Drug Policy"},{"key":"787_CR14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.drugalcdep.2015.12.031","volume":"160","author":"BJH Yarborough","year":"2016","unstructured":"Yarborough BJH, et al. Methadone, buprenorphine and preferences for opioid agonist treatment: a qualitative analysis. Drug Alcohol Depend. 2016;160:112\u20138.","journal-title":"Drug Alcohol Depend"},{"key":"787_CR15","unstructured":"Ball JC, Ross A. The effectiveness of methadone maintenance treatment: patients, programs, services, and outcome. Springer Science & Business Media; 2012."},{"issue":"9","key":"787_CR16","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.3109\/10826084.2011.561905","volume":"46","author":"C Lin","year":"2011","unstructured":"Lin C, Wu Z, Detels R. Opiate users\u2019 perceived barriers against attending methadone maintenance therapy: a qualitative study in China. Substance use & misuse. 2011;46(9):1190\u20138.","journal-title":"Substance use & misuse"},{"key":"787_CR17","doi-asserted-by":"crossref","unstructured":"Mattick RP, et al. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009;3(3).","DOI":"10.1002\/14651858.CD002209.pub2"},{"issue":"1","key":"787_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1747-597X-8-29","volume":"8","author":"Y Liu","year":"2013","unstructured":"Liu Y, et al. Assessment of attitudes towards methadone maintenance treatment between heroin users at a compulsory detoxification Centre and methadone maintenance clinic in Ningbo, China. Substance abuse treatment, prevention, and policy. 2013;8(1):1.","journal-title":"Substance abuse treatment, prevention, and policy"},{"key":"787_CR19","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1016\/S0376-8716(06)80010-4","volume":"82","author":"N Bobrova","year":"2006","unstructured":"Bobrova N, et al. Barriers to accessing drug treatment in Russia: a qualitative study among injecting drug users in two cities. Drug Alcohol Depend. 2006;82:S57\u201363.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"787_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.drugalcdep.2007.11.003","volume":"94","author":"T Clausen","year":"2008","unstructured":"Clausen T, Anchersen K, Waal H. Mortality prior to, during and after opioid maintenance treatment (OMT): a national prospective cross-registry study. Drug Alcohol Depend. 2008;94(1):151\u20137.","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"787_CR21","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1080\/10550490701641157","volume":"16","author":"KM Campbell","year":"2007","unstructured":"Campbell KM, Deck D, Krupski A. Impact of substance abuse treatment on arrests among opiate users in Washington state. Am J Addict. 2007;16(6):510\u201320.","journal-title":"Am J Addict"},{"key":"787_CR22","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.1097\/01.aids.0000304704.71917.64","volume":"21","author":"L Pang","year":"2007","unstructured":"Pang L, et al. Effectiveness of first eight methadone maintenance treatment clinics in China. Aids. 2007;21:S103\u20137.","journal-title":"Aids"},{"issue":"2","key":"787_CR23","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.drugpo.2006.11.014","volume":"18","author":"SG Sullivan","year":"2007","unstructured":"Sullivan SG, Wu Z. Rapid scale up of harm reduction in China. International Journal of Drug Policy. 2007;18(2):118\u201328.","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"787_CR24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1475-6773.2005.00466.x","volume":"41","author":"SL Ettner","year":"2006","unstructured":"Ettner SL, et al. Benefit\u2013cost in the California treatment outcome project: does substance abuse treatment \u201cpay for itself\u201d? Health Serv Res. 2006;41(1):192\u2013213.","journal-title":"Health Serv Res"},{"key":"787_CR25","volume-title":"Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation","author":"M Connock","year":"2007","unstructured":"Connock, M., et al., Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. 2007."},{"issue":"6","key":"787_CR26","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3109\/00952990.2016.1172593","volume":"42","author":"M Khazaee-Pool","year":"2016","unstructured":"Khazaee-Pool M, et al. Psychometric properties of the Persian version of the time to relapse questionnaire (TRQ) in substance use disorder. The American journal of drug and alcohol abuse. 2016;42(6):682\u20138.","journal-title":"The American journal of drug and alcohol abuse"},{"issue":"19","key":"787_CR27","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1001\/jama.2008.648","volume":"300","author":"HD Kleber","year":"2008","unstructured":"Kleber HD. Methadone maintenance 4 decades later. Jama. 2008;300(19):2303\u20135.","journal-title":"Jama"},{"issue":"1","key":"787_CR28","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jsat.2011.01.009","volume":"41","author":"AA Al-Tayyib","year":"2011","unstructured":"Al-Tayyib AA, Koester S. Injection drug users\u2019 experience with and attitudes toward methadone clinics in Denver, CO. J Subst Abus Treat. 2011;41(1):30\u20136.","journal-title":"J Subst Abus Treat"},{"issue":"2","key":"787_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.nedt.2003.10.001","volume":"24","author":"UH Graneheim","year":"2004","unstructured":"Graneheim UH, Lundman B. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today. 2004;24(2):105\u201312.","journal-title":"Nurse Educ Today"},{"issue":"3","key":"787_CR30","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1177\/002204269402400305","volume":"24","author":"JF Maddux","year":"1994","unstructured":"Maddux JF, Prihoda TJ, Desmond DP. Treatment fees and retention on methadone maintenance. J Drug Issues. 1994;24(3):429\u201343.","journal-title":"J Drug Issues"},{"issue":"1","key":"787_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0376-8716(96)01257-4","volume":"42","author":"RE Booth","year":"1996","unstructured":"Booth RE, Crowley TJ, Zhang Y. Substance abuse treatment entry, retention and effectiveness: out-of-treatment opiate injection drug users. Drug Alcohol Depend. 1996;42(1):11\u201320.","journal-title":"Drug Alcohol Depend"},{"key":"787_CR32","volume-title":"A review of the evidence-base for harm reduction approaches to drug use. London: forward thinking on Drugs","author":"N Hunt","year":"2003","unstructured":"Hunt, N., et al., A review of the evidence-base for harm reduction approaches to drug use. London: forward thinking on Drugs, 2003."},{"issue":"11\u201312","key":"787_CR33","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.3109\/10826088509047261","volume":"20","author":"DE Hunt","year":"1985","unstructured":"Hunt DE, et al. \u201cIt takes your heart\u201d: the image of methadone maintenance in the addict world and its effect on recruitment into treatment. Int J Addict. 1985;20(11\u201312):1751\u201371.","journal-title":"Int J Addict"},{"issue":"1","key":"787_CR34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/02791072.1991.10472571","volume":"23","author":"A Rosenblum","year":"1991","unstructured":"Rosenblum A, Magura S, Joseph H. Ambivalence toward methadone treatment among intravenous drug users. J Psychoactive Drugs. 1991;23(1):21\u20137.","journal-title":"J Psychoactive Drugs"},{"issue":"5","key":"787_CR35","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1080\/10550490802268835","volume":"17","author":"RP Schwartz","year":"2008","unstructured":"Schwartz RP, et al. Attitudes toward buprenorphine and methadone among opioid-dependent individuals. Am J Addict. 2008;17(5):396\u2013401.","journal-title":"Am J Addict"},{"issue":"5\u20136","key":"787_CR36","first-page":"347","volume":"67","author":"H Joseph","year":"1999","unstructured":"Joseph H, Stancliff S, Langrod J. Methadone maintenance treatment (MMT): a review of historical and clinical issues. The Mount Sinai Journal of Medicine, New York. 1999;67(5\u20136):347\u201364.","journal-title":"The Mount Sinai Journal of Medicine, New York"},{"issue":"1","key":"787_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7517-10-35","volume":"10","author":"J Csete","year":"2013","unstructured":"Csete J, Catania H. Methadone treatment providers\u2019 views of drug court policy and practice: a case study of New York state. Harm reduction journal. 2013;10(1):1.","journal-title":"Harm reduction journal"},{"issue":"3","key":"787_CR38","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.pec.2008.11.015","volume":"74","author":"RL Street","year":"2009","unstructured":"Street RL, et al. How does communication heal? Pathways linking clinician\u2013patient communication to health outcomes. Patient Educ Couns. 2009;74(3):295\u2013301.","journal-title":"Patient Educ Couns"},{"key":"787_CR39","doi-asserted-by":"crossref","unstructured":"Mohammadpoorasl A, et al. Addiction relapse and its predictors: a prospective study. Journal of Addiction Research & Therapy. 2012;2013","DOI":"10.4172\/2155-6105.1000122"},{"issue":"1","key":"787_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7517-5-13","volume":"5","author":"A Stevens","year":"2008","unstructured":"Stevens A, et al. Early exit: estimating and explaining early exit from drug treatment. Harm Reduction Journal. 2008;5(1):1.","journal-title":"Harm Reduction Journal"},{"issue":"8","key":"787_CR41","first-page":"896","volume":"42","author":"T Pashaei","year":"2013","unstructured":"Pashaei T, et al. Effectiveness of relapse prevention cognitive-behavioral model in opioid-dependent patients participating in the methadone maintenance treatment in Iran. Iranian journal of public health. 2013;42(8):896\u2013902.","journal-title":"Iranian journal of public health"},{"issue":"9148","key":"787_CR42","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0140-6736(98)05356-2","volume":"353","author":"J Ward","year":"1999","unstructured":"Ward J, Hall W, Mattick RP. Role of maintenance treatment in opioid dependence. Lancet. 1999;353(9148):221\u20136.","journal-title":"Lancet"},{"issue":"3","key":"787_CR43","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1046\/j.1360-0443.2002.00083.x","volume":"97","author":"PL Dobkin","year":"2002","unstructured":"Dobkin PL, et al. The role of functional social support in treatment retention and outcomes among outpatient adult substance abusers. Addiction. 2002;97(3):347\u201356.","journal-title":"Addiction"},{"issue":"6","key":"787_CR44","doi-asserted-by":"publisher","first-page":"459","DOI":"10.15288\/jsa.1986.47.459","volume":"47","author":"BS McCrady","year":"1986","unstructured":"McCrady BS, et al. Comparative effectiveness of three types of spouse involvement in outpatient behavioral alcoholism treatment. J Stud Alcohol. 1986;47(6):459\u201367.","journal-title":"J Stud Alcohol"},{"issue":"5","key":"787_CR45","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/j.1465-3362.2010.00173.x","volume":"29","author":"L Brener","year":"2010","unstructured":"Brener L, et al. Perceptions of discriminatory treatment by staff as predictors of drug treatment completion: utility of a mixed methods approach. Drug and Alcohol Review. 2010;29(5):491\u20137.","journal-title":"Drug and Alcohol Review"},{"issue":"1","key":"787_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7517-10-3","volume":"10","author":"F Yang","year":"2013","unstructured":"Yang F, et al. Predictors of retention in community-based methadone maintenance treatment program in Pearl River Delta, China. Harm reduction journal. 2013;10(1):1.","journal-title":"Harm reduction journal"},{"issue":"4","key":"787_CR47","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/jurban\/79.4.571","volume":"79","author":"S Stancliff","year":"2002","unstructured":"Stancliff S, et al. Beliefs about methadone in an inner-city methadone clinic. Journal of Urban Health. 2002;79(4):571\u20138.","journal-title":"Journal of Urban Health"},{"issue":"1","key":"787_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/00952990.2010.540279","volume":"37","author":"AS Saber-Tehrani","year":"2011","unstructured":"Saber-Tehrani AS, Bruce RD, Altice FL. Pharmacokinetic drug interactions and adverse consequences between psychotropic medications and pharmacotherapy for the treatment of opioid dependence. The American journal of drug and alcohol abuse. 2011;37(1):1\u201311.","journal-title":"The American journal of drug and alcohol abuse"},{"issue":"4","key":"787_CR49","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jpain.2014.01.496","volume":"15","author":"MB Weimer","year":"2014","unstructured":"Weimer MB, Chou R. Research gaps on methadone harms and comparative harms: findings from a review of the evidence for an American pain society and college on problems of drug dependence clinical practice guideline. J Pain. 2014;15(4):366\u201376.","journal-title":"J Pain"},{"issue":"3","key":"787_CR50","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1586\/ecp.13.18","volume":"6","author":"RD Bruce","year":"2013","unstructured":"Bruce RD, et al. A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice. Expert Rev Clin Pharmacol. 2013;6(3):249\u201369.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"3","key":"787_CR51","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1521-0391.2012.12004.x","volume":"22","author":"J Gryczynski","year":"2013","unstructured":"Gryczynski J, et al. Patient perspectives on choosing buprenorphine over methadone in an urban, equal-access system. Am J Addict. 2013;22(3):285\u201391.","journal-title":"Am J Addict"},{"issue":"4","key":"787_CR52","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.jsat.2010.07.009","volume":"39","author":"H Pinto","year":"2010","unstructured":"Pinto H, et al. The SUMMIT trial:: a field comparison of buprenorphine versus methadone maintenance treatment. J Subst Abus Treat. 2010;39(4):340\u201352.","journal-title":"J Subst Abus Treat"},{"key":"787_CR53","volume-title":"Experimental study on improving retention at second group of methadone maintenance treatment pilot clinics in Sichuan province. MPH thesis","author":"S Gao","year":"2006","unstructured":"Gao S. Experimental study on improving retention at second group of methadone maintenance treatment pilot clinics in Sichuan province. MPH thesis. Beijing: National Center for AIDS\/STD control and Prevention; 2006."}],"container-title":["International Journal for Equity in Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12939-018-0787-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12939-018-0787-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12939-018-0787-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T17:23:48Z","timestamp":1589909028000},"score":1,"resource":{"primary":{"URL":"https:\/\/equityhealthj.biomedcentral.com\/articles\/10.1186\/s12939-018-0787-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,11]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["787"],"URL":"https:\/\/doi.org\/10.1186\/s12939-018-0787-z","relation":{},"ISSN":["1475-9276"],"issn-type":[{"value":"1475-9276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,11]]},"assertion":[{"value":"23 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval to conduct the study was granted by the Ethics Committee of Kurdistan University of Medical Sciences, Kurdistan, Iran. All participants were informed that their participation was deliberate in this study. Prior to the study, the respondents were informed that their answers would be handled privately and anonymously, and that their names would be replaced by a code. Informed written consent was received from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"75"}}